S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Top-Rated StocksTop-Rated
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Insider Trading & Ownership

$61.32
+1.79 (+3.01%)
(As of 06/2/2023 ET)
Compare
Today's Range
$59.03
▼
$61.66
50-Day Range
$47.88
▼
$66.44
52-Week Range
$42.01
▼
$66.56
Volume
661,392 shs
Average Volume
630,174 shs
Market Capitalization
$5.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.45
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$22.67 M

ITCI Insider Buying and Selling by Quarter

Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Intra-Cellular Therapies Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2023Nostrand Robert L VanDirectorSell10,000$63.00$630,000.009,345  
3/28/2023Mark NeumannEVPSell15,604$54.31$847,453.2445,339  
3/13/2023Lawrence J. HinelineCFOSell5,582$44.93$250,799.26  
3/13/2023Sharon MatesCEOSell20,565$44.99$925,219.351,130,309  
3/13/2023Suresh K DurgamEVPSell7,344$45.04$330,773.7623,104  
3/10/2023Lawrence J. HinelineCFOSell15,663$43.06$674,448.78  
3/10/2023Mark NeumannEVPSell8,550$43.34$370,557.0057,357  
3/10/2023Sharon MatesCEOSell41,770$43.15$1,802,375.501,130,309  
3/1/2023Mark NeumannEVPSell7,241$50.01$362,122.4149,199  
2/24/2023Lawrence J. HinelineCFOSell7,455$47.03$350,608.65  
2/24/2023Mark NeumannEVPSell4,046$47.12$190,647.5256,440  
2/24/2023Sharon MatesCEOSell22,590$47.03$1,062,407.701,100,309  
2/24/2023Suresh K DurgamSVPSell7,906$47.14$372,688.8423,104  
2/21/2023Lawrence J. HinelineCFOSell10,443$46.82$488,941.26  
2/21/2023Mark NeumannEVPSell3,898$47.01$183,244.9852,580  
2/21/2023Sharon MatesCEOSell27,848$46.83$1,304,121.841,100,309  
2/21/2023Suresh K DurgamSVPSell8,354$46.84$391,301.3623,104  
2/17/2023Lawrence J. HinelineCFOSell53,968$49.83$2,689,225.44  
12/19/2022Joel S MarcusDirectorSell5,000$50.82$254,100.0029,233  
12/13/2022Sharon MatesCEOSell33,083$55.00$1,819,565.001,100,309  
12/1/2022Michael HalsteadEVPSell50,000$53.73$2,686,500.00  
9/21/2022Lawrence J. HinelineCFOSell65,164$45.63$2,973,433.32  
8/11/2022Nostrand Robert L VanDirectorSell30,000$57.13$1,713,900.009,043  
(Data available from 1/1/2013 forward)












ITCI Insider Trading Activity - Frequently Asked Questions

Who is on Intra-Cellular Therapies's Insider Roster?

The list of insiders at Intra-Cellular Therapies includes Christopher D Alafi, Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Nostrand Robert L Van, Rory B Riggs, Sharon Mates, and Suresh K Durgam. Learn more on insiders at ITCI.

What percentage of Intra-Cellular Therapies stock is owned by insiders?

3.70% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.

Which Intra-Cellular Therapies insiders have been selling company stock?

The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($1,849,776.03), Lawrence J Hineline ($10,094,662.22), Mark Neumann ($9,944,638.20), Michael Halstead ($11,098,104.28), Nostrand Robert L Van ($2,343,900.00), Rory B Riggs ($5,087,501.84), Sharon Mates ($13,282,189.82), and Suresh K Durgam ($2,531,081.26).

How much insider selling is happening at Intra-Cellular Therapies?

Insiders have sold a total of 1,279,991 Intra-Cellular Therapies shares in the last 24 months for a total of $63,659,310.36 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ITCI) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -